Wnt/β-Catenin Signaling in Cancer
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 31 January 2025 | Viewed by 32
Special Issue Editors
Interests: cancer; gene expression
Interests: molecular biology assessment methods for hereditary susceptibility, gene expression assays, and cellular and tissue phenotypic markers involved in tumor onset and progression.
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The Wnt signaling pathways are implicated in cell fate, migration, and polarity, as well as embryonic organogenesis, stem cell renewal, tissue homeostasis, and epithelial mesenchymal transition (EMT). Wnt signaling involves the canonical or Wnt/β-catenin dependent pathway and the non-canonical or β-catenin-independent pathway, which further comprises the Planar Cell Polarity and the Wnt/Ca2+ pathways. Aberrant activation of Wnt/β-catenin signaling is closely involved in the onset, development, and progression of numerous human malignant tumors and is predictive of poor prognosis. Therefore, deregulation of Wnt may represent an interesting therapeutic target in cancer treatment. So far, despite the efforts of researchers, the pleiotropic role of the Wnt/β-catenin pathway in critical cellular functions and the crosstalk with other signaling pathways have made the design of new targeted drugs difficult.
Understanding the role of Wnt/β-catenin signaling and its crosstalk pathways in cancer development can provide new insights into various pathogenetic mechanisms with the aim (1) to identify molecules of the Wnt signaling cascade that may represent potential prognostic and predictive markers of malignancy and (2) to develop new therapeutic approaches for defining molecular strategies useful in the pharmacological treatment of Wnt-related tumors.
In light of the above, in this Special Issue of the International Journal of Molecular Sciences on ‘Wnt/β-Catenin Signaling in Cancer’, we welcome original basic and translational research and review articles, which may help to elucidate the role played by Wnt signaling in tumor initiation, progression, and therapeutic response.
Dr. Teresa Catalano
Dr. Gitana Maria Aceto
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
-
Wnt/β-catenin pathway
- tumors
- gene expression
- molecular targets
- tumor microenvironment
- carcinogenesis and metastasis
- biomarkers
- therapeutic approaches
